Enteral Nutrition for Premature Birth
(ENACT Trial)
Trial Summary
What is the purpose of this trial?
To test the hypothesis that early exclusive enteral nutrition with the minimal use of parenteral nutrition will improve preterm infants' nutritional outcomes when compared to delayed progression of enteral nutrition and prolonged use of parenteral nutrition.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment Enteral Nutrition for Premature Birth?
Is enteral nutrition safe for premature infants?
Enteral nutrition for premature infants is generally considered safe, but there is a risk of necrotizing enterocolitis (NEC), a serious intestinal disease. Studies show that early and progressive enteral feeding can be done safely in clinically stable preterm infants without increasing the risk of NEC or death, although caution is advised for high-risk infants.16789
How is the treatment of Exclusive Enteral Nutrition different for premature birth?
Exclusive Enteral Nutrition for premature infants focuses on providing nutrition directly to the stomach or intestines, which can help improve growth and reduce complications like feeding intolerance. This approach is different from parenteral nutrition, which delivers nutrients through the veins, and is often used when infants cannot be fed by mouth.1461011
Research Team
Vivek Shukla, MD
Principal Investigator
University of Alabama at Birmingham
Ariel Salas, MD, MSPH
Principal Investigator
University of Alabama at Birmingham
Jacqueline Razzaghy, MD
Principal Investigator
University of Alabama at Birmingham
Eligibility Criteria
This trial is for preterm infants born between 28 and 32 weeks of gestation. It's not suitable for babies with growth restrictions (birth weight below the 10th percentile), major birth defects, or those with terminal illnesses where life support is limited.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either exclusive or progressive enteral nutrition with supplemental parenteral nutrition as needed
Follow-up
Participants are monitored for safety and effectiveness after treatment, including weight, head circumference, and length measurements
Treatment Details
Interventions
- Exclusive Enteral Nutrition
- Progressive Enteral Nutrition
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor